Skip to content
Evigrade
ModerateProton pump inhibitor (PPI)×Selective serotonin reuptake inhibitors (SSRIs)

Updated · Methodology

Mechanism

Sertraline is metabolised in the liver by several pathways, including CYP3A4, CYP2C19 and CYP2B6. In people with slow CYP2C19 activity, its plasma levels are about 50% higher (Besitran SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). According to the Spanish sertraline SmPC, an interaction with strong CYP2C19 inhibitors cannot be excluded. Its examples of such inhibitors include rabeprazole, together with omeprazole, lansoprazole and pantoprazole (Besitran SmPC, AEMPS). The rabeprazole documents themselves do not describe it as a CYP2C19 inhibitor. A significant portion of rabeprazole is broken down without enzymes, and the rest by CYP3A4 and CYP2C19. In healthy volunteers, rabeprazole showed no clinically significant interactions with drugs metabolised by the cytochrome P450 system, including phenytoin (Aciphex label, US Food and Drug Administration, FDA). There is also a link through electrolytes. Severe hypomagnesaemia has been reported with proton pump inhibitors, including rabeprazole, taken for at least three months (Pariet SmPC, AEMPS). Sertraline prolongs the QT interval and is used with caution when potassium or magnesium is low (Besitran SmPC, AEMPS).

Symptoms

The documents describe no symptoms specific to this combination. If sertraline concentrations rise, its common adverse effects may increase: nausea, diarrhoea, dry mouth, insomnia or drowsiness, dizziness, headache and fatigue (Besitran SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). Sertraline prolongs the QT interval, and torsade de pointes has been reported after marketing (Besitran SmPC, AEMPS). Severe hypomagnesaemia with long-term rabeprazole presents with fatigue, tetany, delirium, seizures, dizziness and ventricular arrhythmia, and it can begin insidiously (Pariet SmPC, AEMPS).

Management

The combination is not contraindicated, and the documents give no measures specific to this pair. According to the Spanish sertraline SmPC, an interaction with rabeprazole as a strong CYP2C19 inhibitor cannot be excluded (Besitran SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). In people with slow CYP2C19 activity, who have higher sertraline levels, the dose is adjusted according to clinical response (Besitran SmPC, AEMPS). The US labels for sertraline and rabeprazole do not name this pair. In healthy volunteers, rabeprazole had no clinically significant interactions with drugs metabolised by the cytochrome P450 system (Zoloft and Aciphex labels, US Food and Drug Administration, FDA). Sertraline is used with caution in people with risk factors for QT prolongation, including hypokalaemia and hypomagnesaemia (Besitran SmPC, AEMPS). If rabeprazole is taken long term, doctors consider measuring blood magnesium before treatment and periodically afterwards (Pariet SmPC, AEMPS).

Your whole list in one report

Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email

Add more drugs

Medicine list: everything you take in one place →

Sources

Other interactions with Rabeprazole

Other interactions with Sertraline